Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 8561-8570 of 13616

Page
per page
  1. Fmoc-Ala-Ala-OH
    BA9328 Fmoc-Ala-Ala-OH
    Summary: Fmoc-Ala-Ala-OH(3) is a self-assembled fluorenylmethoxycarbonyl dipeptide, a small amphiphilic building block consisting of a dipeptide attached to a fluorenylmethoxycarbonyl (Fmoc).
  2. Plixorafenib
    C9064 Plixorafenib
    Summary: A selective BRAF inhibitor for research use, suitable for in vitro studies of the MAPK pathway.
      ≥55.8 mg/mL
  3. KD 5170
    A4493 KD 5170
     1 Citation
    Summary: HDAC inhibitor
      ≥21.2 mg/mL
  4. TC-A 2317 hydrochloride
    A4489 TC-A 2317 hydrochloride
    Target: Aurora Kinases
    Summary: Aurora kinase A inhibitor,potent and selective
      <39.29 mg/mL
  5. Cycloheximide
    A8244 Cycloheximide
     63 Citation
    Summary: protein biosynthesis inhibitor
      ≥14.05 mg/mL
  6. Afatinib (BIBW2992)
    A8247 Afatinib (BIBW2992)
     2 Citation
    Target: EGFR
    Summary: Irreversible EGFR/HER2 inhibitor
      ≥24.3 mg/mL
  7. LY 294002
    A8250 LY 294002
     70 Citation
    Target: PI3K
    Summary: Potent PI3K inhibitor
  8. Verteporfin
    A8327 Verteporfin
     11 Citation
    Target: YAP
    Summary: Photosensitizer used in photodynamic therapy
      insoluble in EtOH; insoluble in H2O; ≥18.3 mg/mL
  9. PHA-848125
    A8501 PHA-848125
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor,potent and ATP-competitive
      ≥23.05 mg/mL
  10. Viomycin
    A8645 Viomycin
    Summary: Antibiotic of tuberactinomycin family
      <66.14 mg/mL

Items 8561-8570 of 13616

Page
per page